Mood Stabilizers (Lithium)

High-yield High-alert Verified · Jul 2026

Prototype: lithium carbonate

Lithium — the classic mood stabilizer; a narrow-index drug where dehydration and drug interactions cause toxicity.

How it works in the body

The system involved, what goes wrong, and how the drug and body interact.

01 Bipolar disorder and mood stabilization

Bipolar disorder swings between mania (elevated/irritable mood, racing thoughts, impulsivity, little sleep) and depression. A mood stabilizer flattens those swings — controlling acute mania and, importantly, preventing future episodes. Lithium is the prototype and remains first-line, uniquely reducing suicide risk in bipolar disorder.

Several anticonvulsants double as mood stabilizers — valproate (acute mania) and lamotrigine (bipolar depression/maintenance) — which is why this class overlaps the Anticonvulsants page. But lithium is the one that defines the class’s central nursing challenge: the level.

02 Why the level rules everything — a narrow window

Lithium has one of the narrowest therapeutic indices in medicine. The target is roughly 0.6–1.2 mEq/L (lower for maintenance, up to ~1.0–1.2 for acute mania), and toxicity begins not far above — around 1.5 mEq/L, becoming severe above 2.5 mEq/L. The effective dose sits dangerously close to the toxic one, so blood levels are checked routinely and drawn as a trough (~12 h after the last dose).

The reason toxicity is so easy to trigger is that lithium is handled like sodium by the kidney. Anything that makes the kidney hold onto sodium makes it hold onto lithium too — so the level climbs.

03 The sodium/water connection — how toxicity sneaks up

When the body is sodium-depleted or dehydrated (vomiting, diarrhea, sweating, low-salt diet, fever), the kidney reabsorbs more sodium — and reabsorbs more lithium with it, pushing the level up. The same thing happens with three common drug classes: thiazide diuretics, NSAIDs, and ACE inhibitors/ARBs all reduce lithium clearance and can precipitate toxicity within days.

So the safety rules follow directly from the mechanism: keep hydration and salt intake steady, watch for anything that causes fluid loss, and screen every new drug for a lithium interaction. Early toxicity is GI upset, coarse tremor, and confusion; severe toxicity brings ataxia, slurred speech, seizures, and arrhythmias.

Loading diagram…

Dehydration, low salt, and thiazides/NSAIDs/ACE-I all make the kidney retain lithium → toxicity.

Drug names

Generic Brand

lithium carbonate Lithobid

valproate / divalproex Depakote

lamotrigine Lamictal

Indications

Bipolar disorder — acute mania and long-term maintenance (relapse prevention)
Reduction of suicide risk in bipolar disorder (lithium)
Augmentation in treatment-resistant depression

Mechanism of action

Not fully understood; lithium modulates neuronal signaling (interfering with second-messenger systems such as inositol monophosphate and GSK-3), stabilizing mood. Valproate and lamotrigine stabilize mood via anticonvulsant mechanisms (see Anticonvulsants).

In plain terms

Lithium steadies the brain’s mood signaling, smoothing out the highs of mania and the lows of depression.

Therapeutic effects — what you'll see working

Success is fewer and milder mood episodes over time — judged clinically and by keeping the serum level in the narrow target window. Full mood-stabilizing effect takes 1–2 weeks or more.

Controls acute mania Prevents relapse ↓ Suicide risk

Controls acute mania: Reduces the elevated mood, racing thoughts, and impulsivity of a manic episode over days to weeks.
Prevents relapse: Long-term use reduces the frequency and severity of both manic and depressive episodes — the core goal of maintenance therapy.
↓ Suicide risk: Lithium uniquely lowers suicide risk in bipolar disorder, a benefit not shared by all mood stabilizers.

Adverse effects

Lithium’s adverse effects split into expected therapeutic-range effects (tremor, thirst, weight gain, thyroid/kidney) and dose-related toxicity — the two are separated by a very thin margin, so recognizing early toxicity is essential.

Common (therapeutic range)

Fine hand tremor, increased thirst and urination, nausea, weight gain, metallic taste.

A fine tremor, polyuria/polydipsia (lithium can cause a nephrogenic diabetes insipidus–like effect), and GI upset are common even at correct levels. A coarsening tremor, by contrast, is an early warning of rising toxicity.

Serious Report immediately

Lithium toxicity (ataxia, confusion, slurred speech, seizures, arrhythmia); hypothyroidism; nephrogenic diabetes insipidus / chronic kidney effects.

Toxicity escalates from GI upset and coarse tremor to ataxia, confusion, slurred speech, seizures, coma, and arrhythmias — a medical emergency (hemodialysis for severe cases). Long-term lithium can cause hypothyroidism and renal impairment, so thyroid and kidney function are monitored periodically.

Antidote

No specific antidote

Toxicity → hold, hydrate, correct sodium; hemodialysis for severe toxicity.

Interactions

NSAIDs, thiazide diuretics, ACE inhibitors drug

Raise serum lithium → toxicity.

Low sodium intake / dehydration food

Kidney retains lithium → toxicity; keep salt & fluids consistent.

Contraindications

The contraindications are the states that let lithium accumulate or that lithium worsens.

Significant renal impairment

Lithium is cleared entirely by the kidney; impaired clearance causes rapid accumulation to toxic levels.

Significant dehydration / sodium depletion

Sodium loss makes the kidney reabsorb more lithium, driving the level into the toxic range.

Pregnancy (first trimester — relative) use caution

Associated with cardiac malformations (Ebstein anomaly); weigh risk vs benefit and monitor closely.

Concurrent thiazide diuretics, NSAIDs, or ACE inhibitors/ARBs use caution

Each reduces lithium clearance and can precipitate toxicity — avoid or monitor levels closely.

When to hold

Assess before giving — these findings mean hold the dose and act.

Signs of toxicity — coarse tremor, ataxia, confusion, vomiting/diarrhea

Hold, obtain a lithium level, and notify.

Dehydration, low sodium, or new NSAID/diuretic/ACE inhibitor

Reassess — these raise lithium levels.

Labs & levels

Test Therapeutic / normal Toxic / critical

Lithium level Draw **12 h after the dose**; check frequently when starting Therapeutic 0.6–1.2 mEq/L (maintenance) > 1.5 mEq/L

Nursing considerations

The RN-specific layer — each action paired with the reason it matters.

Level monitoring

Draw lithium levels regularly (frequently at initiation, then every few months) as a 12-hour trough; target ~0.6–1.2 mEq/L.

Why: The therapeutic window is tiny; scheduled trough levels are the only way to keep the dose safe and effective.

Hold and notify the prescriber for signs of toxicity or a level > 1.5 mEq/L.

Why: Toxicity can be life-threatening; early GI upset, coarse tremor, and confusion warrant an immediate level.

Monitor renal and thyroid function periodically.

Why: Long-term lithium can impair the kidney and thyroid, and renal decline further raises levels.

Patient teaching

Maintain consistent fluid and salt (sodium) intake; report vomiting, diarrhea, heavy sweating, or fever.

Why: Dehydration and sodium loss raise lithium levels; steady intake keeps the level stable.

Avoid NSAIDs (use acetaminophen) and check before starting any new drug/diuretic.

Why: NSAIDs, thiazides, and ACE inhibitors reduce lithium clearance and can cause toxicity.

Learn the early toxicity signs — coarse tremor, GI upset, confusion, unsteadiness, slurred speech — and seek care promptly.

Why: Recognizing toxicity early prevents progression to seizures, coma, and arrhythmia.

Sources

Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.